Antidepressants for depressed elderly (Q24244664)

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Cross-over trial comparing the antidepressant effects of amineptine and maprotiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Clinical assessment and performance tasks in depression: a comparison of amitriptyline and trazodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Changes in cognitive functioning following treatment of late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

A comparative study of the therapeutic effect and cardiotoxicity of dothiepin HCl and doxepin HCl in reactive depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Accelerating antidepressant response in geriatric depression: a post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

A Comparative Investigation of Desipramine and Nortriptyline in the Treatment of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Predicting response to fluoxetine in geriatric patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Controlled Trial of Nomifensin (HOE 984) and Viloxazine in the Treatment of Depression in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Brofaromine in elderly major depressed patients--a comparative trial versus imipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

The effects of acute scopolamine in geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Predictors of response to amine-specific antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Cardiovascular Effects of Fluoxetine in Depressed Patients With Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Issues in clinical trials with the depressed elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

A comparative trial of desipramine and nortriptyline in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Desipramine increases circulating growth hormone in elderly depressed patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Diagnostic Criteria for Use in Psychiatric Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

Cognitive performance in geriatric subjects after acute treatment with antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

A SELF-RATING DEPRESSION SCALE

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

A Controlled Trial of Antidepressant Medication in Elderly In-Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A double-blind comparison of dothiepin and amitriptyline for the treatment of depression with anxiety

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Cardiovascular effect of imipramine and nortriptyline in elderly patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Dose-dependent kinetics of imipramine in elderly patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Post-stroke depression: combined treatment with imipramine or desipramine and mianserin

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Clinical predictors of response to antidepressants in elderly patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

The usefulness of DST in predicting response to antidepressants: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Amineptine in the management of the depressive syndromes

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Brofaromine versus imipramine in in-patients with major depression – a controlled trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Double-blind, multicenter comparative study of sertraline versus amitriptyline in outpatients with major depression

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

[Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)]

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Treating geriatric depression: a 26-week interim analysis

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A comparison of the cardiac safety and therapeutic efficacy of trimipramine versus doxepin in geriatric depressed patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A double blind comparison of zimelidine and amitriptyline in endogenous depression

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Trazodone. A comparative clinical and predictive study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Moclobemide compared with second-generation antidepressants in elderly people

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

The impact of treatment resistance on depressive relapse following electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Double‐blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major dipressive episode

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Are there any differences in the safety and efficacy of brofaromine and imipramine between non-elderly and elderly patients with major depression?

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

10-Hydroxynortriptyline and treatment effects in elderly depressed patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

COMPARATIVE TRIAL OF NORTRIPTYLINE AND AMITRIPTYLINE

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

A Comparison of the Therapeutic and Cardiovascular Effects of a Single Nightly Dose of Prothiaden (Dothiepin, Dosulepin) and Lentizol (Sustained-Release Amitriptyline) in Depressed Elderly Patients

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Primary care treatment of depression in the elderly: a double-blind, multi-centre study of flupenthixol ('Fluanxol') and sustained-release amitriptyline

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Social origins of depression in old age

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Nefazodone and imipramine in major depression: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Buspirone and Imipramine for the Treatment of Major Depression in the Elderly

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly

1 reference

https://api.crossref.org/works/10.1002/14651858.CD003491.PUB2

7 January 2021